Literature DB >> 22983394

Tanshinone IIA protects rabbits against LPS-induced disseminated intravascular coagulation (DIC).

Liang-Cai Wu1, Xi Lin, Hao Sun.   

Abstract

AIM: To evaluate the effects of tanshinone IIA (Tan IIA), a lipophilic diterpene from the Chinese herb Salvia miltiorrhiza, on lipopolysaccharide (LPS)-induced disseminated intravascular coagulation (DIC) in rabbits.
METHODS: LPS-induced DIC model was made in adult male New Zealand rabbits by continuous intravenous infusion of LPS (0.5 mg/kg) via marginal ear vein for 6 h. The animals were simultaneously administered with Tan IIA (1, 3 and 10 mg/kg) or heparin (500 000 IU/kg) through continuous infusion via the contralateral marginal ear vein for 6 h. Before and 2 and 6 h after the start of LPS infusion, blood samples were taken for biochemical analyses.
RESULTS: Continuous infusion of LPS into the rabbits gradually impaired the hemostatic parameters, damaged renal and liver functions, increased the plasma TNF-α level, and led to a high mortality rate (80%). Treatment of the rabbits with Tan IIA dose-dependently attenuated the increase in activated partial thromboplastin time (APTT), prothrombin time (PT) and fibrin-fibrinogen degradation products (FDP); ameliorated the decrease in plasma levels of fibrinogen and platelets; and reversed the decline in activity of protein C and antithrombin III. Meanwhile, the treatment significantly suppressed the increase in the plasma levels of aminotransferase, creatinine and TNF-α, and led to much lower mortality (46.7% and 26.7% for the medium- and high-dose groups). Treatment of the rabbits with the high dose of heparin also effectively improved the hemostatic parameters, ameliorated liver and renal injuries, and reduced the plasma level of TNF-α, and significantly reduced the mortality (33.3%).
CONCLUSION: Tan IIA exerts a protective effect against DIC in rabbits.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983394      PMCID: PMC4002711          DOI: 10.1038/aps.2012.84

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  23 in total

1.  A new platelet aggregation inhibitor from Salvia miltiorrhiza.

Authors:  N Wang; H W Luo; M Niwa; J Ji
Journal:  Planta Med       Date:  1989-08       Impact factor: 3.352

Review 2.  [Treatment of DIC associated with myelogenous leukemia].

Authors:  Yoichi Sakata
Journal:  Nihon Rinsho       Date:  2009-10

3.  Association between necropsy evidence of disseminated intravascular coagulation and coagulation variables before death in patients in intensive care units.

Authors:  J T Wilde; K M Roberts; M Greaves; F E Preston
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

4.  Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity.

Authors:  T A Warr; L V Rao; S I Rapaport
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

5.  Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin.

Authors:  A M Taveira da Silva; H C Kaulbach; F S Chuidian; D R Lambert; A F Suffredini; R L Danner
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

6.  Disseminated intravascular coagulation during heparin therapy.

Authors:  H G Klein; W R Bell
Journal:  Ann Intern Med       Date:  1974-04       Impact factor: 25.391

7.  Studies on cardiovascular actions of Salvia miltiorrhiza.

Authors:  X L Lei; G C Chiou
Journal:  Am J Chin Med       Date:  1986       Impact factor: 4.667

8.  PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice.

Authors:  Gernot Schabbauer; Michael Tencati; Brian Pedersen; Rafal Pawlinski; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-19       Impact factor: 8.311

9.  [Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models].

Authors:  S Hamano; M Kinukawa; H Komatsu; H Miyata; N Sakuragawa
Journal:  Nihon Yakurigaku Zasshi       Date:  1991-07

10.  Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.

Authors:  Y Fong; K J Tracey; L L Moldawer; D G Hesse; K B Manogue; J S Kenney; A T Lee; G C Kuo; A C Allison; S F Lowry
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  11 in total

1.  Danhong Huayu Koufuye combined with metformin attenuated diabetic retinopathy in Zucker diabetic fatty rats.

Authors:  Wen-Pei Chen; Yan-Dong Wang; Yan Ma; Zi-Yang Zhang; Lu-Yun Hu; Jun-Li Lin; Bao-Qin Lin
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

2.  Identification of blood-activating components from Xueshuan Xinmaining Tablet based on the spectrum-effect relationship and network pharmacology analysis.

Authors:  Jing Tan; Junli Liu; Han Wang; Ying Zhang; Hongqiang Lin; Zhongyao Wang; Hanrui Si; Yutong Zhang; Jinping Liu; Pingya Li; Kai Sun
Journal:  RSC Adv       Date:  2020-03-10       Impact factor: 4.036

3.  Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.

Authors:  Lili Zhang; Lin Han; Xinmiao Wang; Yu Wei; Jinghui Zheng; Linhua Zhao; Xiaolin Tong
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

4.  Tanshinone-1 induces tumor cell killing, enhanced by inhibition of secondary activation of signaling networks.

Authors:  L Xu; J-M Feng; J-X Li; J-M Zhu; S-S Song; L-J Tong; Y Chen; X-Y Yang; Y-Y Shen; F-L Lian; Y-P Li; D-H Lin; J Ding; Z-H Miao
Journal:  Cell Death Dis       Date:  2013-11-07       Impact factor: 8.469

Review 5.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

6.  A commonly used Chinese herbal formula, Shu-Jing-Hwo-Shiee-Tang, potentiates anticoagulant activity of warfarin in a rabbit model.

Authors:  Sien-Hung Yang; Chia-Li Yu; Hsing-Yu Chen; Yi-Hsuan Lin
Journal:  Molecules       Date:  2013-09-25       Impact factor: 4.411

7.  Antifatigue properties of tanshinone IIA in mice subjected to the forced swimming test.

Authors:  Chueh-Yu Lin; Yan-Shu Jhang; Shang-Chi Lai; En-Li Chen; I-Hsin Lin; Tung-Wu Chang; Yu-Wei Tseng; Vaishnavi Seenan; Jane Shiung; Ming-Hua Chen; Yun-Chen Chiang; Tsung-I Chen; Yin-Jeh Tzeng
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 8.  To What Extent Are the Terminal Stages of Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome Actually Driven by a Prion/Amyloid Form of Fibrin?

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Semin Thromb Hemost       Date:  2017-08-04       Impact factor: 4.180

9.  A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease.

Authors:  Shao-hua Shi; Yue-piao Cai; Xiao-jun Cai; Xiao-yong Zheng; Dong-sheng Cao; Fa-qing Ye; Zheng Xiang
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

10.  Pharmacokinetics and tissue distribution study of tanshinone IIA after oral administration of Bushen Huoxue Qubi granules to rats with blood stasis syndrome.

Authors:  Yuanqing Wang; Jianye Yan; Shunxiang Li; Xiong Cai; Wei Wang; Kun Luo; Dan Huang; Jiesheng Gao
Journal:  Pharmacogn Mag       Date:  2014-07       Impact factor: 1.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.